COCP — Cocrystal Pharma Inc · rev $105.0K

Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.

Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.

Use this COCP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the COCP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the COCP SEC filings page. Lician reads the product cache first so this HTML stays unique to Cocrystal Pharma Inc even when a live quote feed is slow.

Cocrystal Pharma Inc latest statements (FY2025)

Latest cached year on this hub. Full COCP income, balance, and cash tables.

  • Revenue$0
  • Net Income-$8.8M
  • Total Assets$9.7M
  • Total Debt$0
  • Free Cash Flow-$8.2M

COCP recent filings